Dividend Roundup: AGNC Investments, Abbott Labs, AbbVie, and more
2026-04-10 08:00:22 ET
More related stories
- AbbVie: Fairly Valued And Positioned For Growth
- AbbVie: Buy Or Sell Ahead Of Q1 Earnings? It's A Buy, But With Caveats (Upgrade)
- Abbott Laboratories: A Dividend Aristocrat With A Compelling Valuation And Return Potential
- Agree Realty raises monthly dividend by 1.9% to $0.267 a share
- Chicago jury orders Abbott to pay $53M in preterm infant formula trial
Read the full article on Seeking Alpha
For further details see:
Dividend Roundup: AGNC Investments, Abbott Labs, AbbVie, and moreNASDAQ: AYI
AYI Trading
-3.26% G/L:
$300.95 Last:
61,889 Volume:
$305.74 Open:



